BCC 2025 | Assessing the impact of bilateral oncoplastic surgery on PROs in breast cancer

Martin Heidinger • 13 Mar 2025

BCC 2025

Breast Cancer

Martin Heidinger, MD, University Hospital Basel, Basel, Switzerland, describes the effect of immediate symmetrizing oncoplastic surgery on patient-reported outcomes (PROs) in patients with breast cancer. A retrospective study found no significant differences in outcomes between unilateral and bilateral surgery groups. However, bilateral surgery was associated with a higher risk of short-term surgical complications, which negatively impacted patient-reported outcomes. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.